Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02516670
What this trial is testing

Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaStage IV Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Testing effectiveness (Phase 2)Looking for participantsNCT07181161
What this trial is testing

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 283
Not applicableEnded earlyNCT03073473
What this trial is testing

Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers

Who this might be right for
Pancreatic CancerMetastatic Breast CancerMetastatic Lung Cancer+3 more
Cota Inc. 40
Not applicableStudy completedNCT06204302
What this trial is testing

An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States

Who this might be right for
Non-metastatic Prostate CancerNon-metastatic Castration-resistant Prostate Cancer
Bayer 1,800
Large-scale testing (Phase 3)Active Not RecruitingNCT02051218
What this trial is testing

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Who this might be right for
Metastatic Breast CancerMetastatic Prostate CancerBone Metastases
Swiss Cancer Institute 1,380
Large-scale testing (Phase 3)Not Yet RecruitingNCT07632690
What this trial is testing

QLC5508 in Participants With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Qilu Pharmaceutical Co., Ltd. 700
Testing effectiveness (Phase 2)Study completedNCT01558219
What this trial is testing

Second-line Chemotherapy in Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Tampere University Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04104893
What this trial is testing

CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
VA Office of Research and Development 40
Testing effectiveness (Phase 2)Study completedNCT03434158
What this trial is testing

Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL)

Who this might be right for
Prostate Cancer Metastatic
Spanish Oncology Genito-Urinary Group 16
Early research (Phase 1)Study completedNCT06566989
What this trial is testing

The Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008)

Who this might be right for
Metastatic Prostate Cancer
Merck Sharp & Dohme LLC 8
Early research (Phase 1)Looking for participantsNCT07824349
What this trial is testing

JUR-003 in Adult Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate CancerOligometastatic Prostate Cancer (OMPC)Metastatic Hormone Sensitive Prostate Cancer
Juri Biosciences, Inc. 210
Testing effectiveness (Phase 2)Looking for participantsNCT06616597
What this trial is testing

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 58
Not applicableStudy completedNCT04545697
What this trial is testing

MHealth ElectroNic COnsultation REcording (mENCORE) in Advanced Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
University of California, San Francisco 27
Testing effectiveness (Phase 2)Study completedNCT04179968
What this trial is testing

The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer Metastatic
Dana Mathews 20
Testing effectiveness (Phase 2)Ended earlyNCT01735396
What this trial is testing

Abiraterone Acetate Trial in African American Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 11
Large-scale testing (Phase 3)Active Not RecruitingNCT05936658
What this trial is testing

[18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer

Who this might be right for
High Risk Prostate Carcinoma
FutureChem 138
Not applicableLooking for participantsNCT05850182
What this trial is testing

Lifestyle Intervention in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Oncology Institute of Southern Switzerland 30
Early research (Phase 1)Study completedNCT03569280
What this trial is testing

Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients

Who this might be right for
Castration-Resistant Prostate Cancer
Kangpu Biopharmaceuticals, Ltd. 16
Testing effectiveness (Phase 2)Ended earlyNCT01145508
What this trial is testing

Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Ended earlyNCT00176527
What this trial is testing

Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
University of Medicine and Dentistry of New Jersey 40
Next Page